Rheumatoid Arthritis

Showing NaN - NaN of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatoid Arthritis Trial in Worldwide (PF-05280586, MabThera, Rituxan)

Completed
  • Rheumatoid Arthritis
  • PF-05280586
  • +2 more
  • Birmingham, Alabama
  • +83 more
Oct 30, 2019

Rheumatoid Arthritis Trial in Worldwide (Baricitinib, Methotrexate, Baricitinib Placebo)

Completed
  • Rheumatoid Arthritis
  • Glendale, Arizona
  • +153 more
Sep 9, 2019

Rheumatoid Arthritis Trial in Worldwide (Adalimumab, Baricitinib, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Glendale, Arizona
  • +212 more
Sep 9, 2019

Rheumatoid Arthritis Trial in Worldwide (Placebo, Baricitinib, cDMARD)

Completed
  • Rheumatoid Arthritis
  • Placebo
  • +2 more
  • Glendale, Arizona
  • +146 more
Sep 9, 2019

Rheumatoid Arthritis Trial in Worldwide (Placebo, Baricitinib, cDMARD)

Completed
  • Rheumatoid Arthritis
  • Placebo
  • +2 more
  • Glendale, Arizona
  • +102 more
Sep 9, 2019

Rheumatoid Arthritis Trial in Worldwide (Leflunomide, Methotrexate, Ocrelizumab)

Terminated
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +265 more
Aug 8, 2019

Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis Trial in United States (Cormet Hip Resurfacing)

Completed
  • Osteoarthritis
  • +2 more
  • Cormet Hip Resurfacing
  • Washington, District of Columbia
  • +5 more
Jun 12, 2019

Rheumatoid Arthritis Trial in Worldwide (Etanercept, CHS-0214)

Completed
  • Rheumatoid Arthritis
  • Phoenix, Arizona
  • +140 more
Jun 7, 2019

Rheumatoid Arthritis Trial in Puerto Rico, United States (Itacitinib, Itacitinib Placebo)

Completed
  • Rheumatoid Arthritis
  • Palm Desert, California
  • +17 more
Mar 8, 2019

Rheumatoid Arthritis Trial in Worldwide (Rituximab-Pfizer (PF-05280586) x 3 courses, Rituximab-EU+ Rituximab-Pfizer x 2 Courses,

Completed
  • Rheumatoid Arthritis
  • Rituximab-Pfizer (PF-05280586) x 3 courses
  • +2 more
  • Birmingham, Alabama
  • +70 more
Jan 8, 2019

Rheumatoid Arthritis Trial in Worldwide (Adalimumab - GP2017, Adalimumab - US licensed Humira)

Completed
  • Rheumatoid Arthritis
  • Adalimumab - GP2017
  • Adalimumab - US licensed Humira
  • Mesa, Arizona
  • +82 more
Nov 30, 2018

Rheumatoid Arthritis Trial in Worldwide (GP2015)

Completed
  • Rheumatoid Arthritis
  • Peoria, Arizona
  • +91 more
Sep 18, 2018

Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )

Terminated
  • Inflammation
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +163 more
Sep 3, 2018

Rheumatoid Arthritis, Psoriatic Arthritis Trial in United States (Etanercept / Autoinjector A)

Completed
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Etanercept / Autoinjector A
  • Huntsville, Alabama
  • +12 more
Aug 1, 2018

Rheumatoid Arthritis, Plaque Psoriasis Trial in Canada, United States (Etanercept via Autoinjector A, Etanercept via

Completed
  • Rheumatoid Arthritis
  • Plaque Psoriasis
  • Etanercept via Autoinjector A
  • Etanercept via Autoinjector B
  • Huntsville, Alabama
  • +36 more
Aug 1, 2018

Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)

Completed
  • Rheumatoid Arthritis
  • Certolizumab Pegol
  • Huntsville, Alabama
  • +60 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Worldwide (Certolizumab pegol (CZP), Placebo)

Completed
  • Rheumatoid Arthritis
  • Certolizumab pegol (CZP)
  • Placebo
  • Birmingham, Alabama
  • +180 more
Jul 4, 2018

Rheumatoid Arthritis Trial in United States (Certolizumab Pegol (CZP))

Completed
  • Rheumatoid Arthritis
  • Certolizumab Pegol (CZP)
  • Birmingham, Alabama
  • +109 more
Jul 4, 2018

Rheumatoid Arthritis Trial in Palm Harbor, Tampa (prednisone)

Completed
  • Rheumatoid Arthritis
  • Palm Harbor, Florida
  • +1 more
Jul 25, 2018

Rheumatoid Arthritis Trial in United States (Adalimumab delivered in current syringe, Adalimumab delivered in Physiolis syringe,

Completed
  • Rheumatoid Arthritis
  • Adalimumab delivered in current syringe
  • +3 more
  • Victorville, California
  • +9 more
Jun 1, 2018

Rheumatoid Arthritis Trial in Worldwide (LY2127399)

Terminated
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +326 more
May 11, 2018

Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo Q4W, Placebo Q2W)

Terminated
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +200 more
May 11, 2018

Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo Q2W, Placebo Q4W)

Terminated
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +233 more
May 4, 2018

Rheumatoid Arthritis Trial in United States (Tofacitinib, Placebo)

Completed
  • Rheumatoid Arthritis
  • Jonesboro, Arkansas
  • +35 more
Mar 13, 2018

Rheumatoid Arthritis Trial in Worldwide (GP2013 - A Proposed biosimilar rituximab, Originator rituximab - Rituxan ® or MabThera

Completed
  • Rheumatoid Arthritis
  • GP2013 - A Proposed biosimilar rituximab
  • Originator rituximab - Rituxan ® or MabThera ®
  • Huntsville, Alabama
  • +64 more
Nov 30, 2017